Fast-Tracking Growth: Pakistan’s Bold Vision for Medical Exports

Pakistan is setting its sights high—very high. The country plans to elevate its pharmaceutical and medical device exports to a staggering $30 billion over the next five years. This ambitious goal was announced by Federal Health Minister Syed Mustafa Kamal during a review meeting with the Drug Regulatory Authority of Pakistan (DRAP).

Currently, Pakistan’s medical exports hover below the $1 billion mark. But with a new fast-track licensing system and strategic partnerships, the government is determined to transform the sector into a global powerhouse.

“This is not just a numerical goal—it represents Pakistan’s economic resilience and our determination to strengthen the national economy,” Kamal stated. He emphasized that the Ministry of Health and DRAP are working closely to ensure timely implementation of reforms that will open doors to major international healthcare markets.

The plan includes streamlining regulatory processes, enhancing collaboration with the Medical Devices Association, and aligning local standards with global expectations. These steps aim to make Pakistani pharmaceutical and medical device manufacturers more competitive on the world stage.

Regular follow-up meetings will be held to monitor progress, ensuring that the initiative stays on track. The ultimate vision is to turn Pakistan’s health sector into an export-driven engine of economic growth.

With the right infrastructure, policy support, and industry collaboration, Pakistan’s $30 billion target may not be just a dream—but a future within reach.